Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IB/II Study of Venetoclax (ABT-199) in Combination With Liposomal Vincristine or Vincristine Sulfate in Patients With Relapsed or Refractory T-Cell or B-Cell Acute Lymphoblastic Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03504644
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:04.293307+00:00
Published At
2026-02-25T00:00:00+00:00
Record Updated At
2026-04-02
Results Posted At
2026-02-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Adult Lymphoblastic Lymphoma", "Recurrent B Acute Lymphoblastic Leukemia", "Recurrent B Lymphoblastic Lymphoma", "Recurrent T Acute Lymphoblastic Leukemia", "Recurrent T Lymphoblastic Lymphoma", "Refractory B Acute Lymphoblastic Leukemia", "Refractory B Lymphoblastic Lymphoma", "Refractory T Acute Lymphoblastic Leukemia", "Refractory T Lymphoblastic Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-02"
protocolSection.identificationModule.nctId
"NCT03504644"
protocolSection.identificationModule.officialTitle
"A Phase IB/II Study of Venetoclax (ABT-199) in Combination With Liposomal Vincristine or Vincristine Sulfate in Patients With Relapsed or Refractory T-Cell or B-Cell Acute Lymphoblastic Leukemia"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-02-25"

Study condition terms

  • Recurrent Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent B Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent B Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent T Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Recurrent T Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory B Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory B Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory T Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Refractory T Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.